ACM
ADMA icon

Aquatic Capital Management’s ADMA Biologics ADMA Stock Holding History

Aquatic Capital Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27
Closed -$463 – 1229
2024
Q4 		$463 Buy
+27
New +$508 ﹤0.01% 1278
2022
Q3 		– Sell
-36,000
Closed -$71K – 1136
2022
Q2 		$71K Buy
36,000
+31,000
+620% +$61K 0.02% 569
2022
Q1 		$9K Buy
5,000
+4,600
+1,150% +$7.18K 0.01% 677
2021
Q4 		$1K Buy
+400
New +$526 ﹤0.01% 1069

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Aquatic Capital Management's ADMA Position: Q1 2025 in Review

Aquatic Capital Management sold out of ADMA Biologics (ADMA) in Q1 2025, closing a stake of 27 shares — an estimated $463 sold.

Aquatic Capital Management first reported a position in ADMA in Q4 2021 and held it in 4 quarters. The position peaked at $71K in Q2 2022. 347 funds tracked by Wall St. Rank hold ADMA as of Q1 2025.

  • Aquatic Capital Management reported no remaining ADMA Biologics position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 27 ADMA Biologics shares in Q1 2025, an estimated $463.
  • Aquatic Capital Management first reported a position in ADMA Biologics in Q4 2021 and held it in 4 quarters.
  • Aquatic Capital Management's ADMA Biologics position peaked at $71K in Q2 2022.
  • 347 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.